Plain Language Review: What are Biosimilar Medicines and how Can they be Used to Treat People with Cancer?

Manwar Al-Naqqash1 Department of Surgery, College of Medicine, University of Baghdad, Baghdad, Iraq;2 Oncology Teaching Hospital, Medical City Complex, Baghdad, Iraq

Gilberto Castañeda-Hernández3 Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico

Shao-Chin Chiang4 Koo Foundation Sun Yat-Sen Cancer Center Department of Pharmacy, National Yang Ming Chiao Tung University, Taipei, Taiwan

Fahad Ibnshamsah5 Department of Adult Medical Oncology, King Fahd Specialist Hospital in Dammam, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia

Tomás Reinert6 Oncoclínicas, Porto Alegre, Brazil

Robert M Rifkin7 Rocky Mountain Cancer Centers, US Oncology Research, Denver, CO, USA

Waleed El Morsi8 Pfizer Inc, Dubai, UAE

show all

Plain Language Review: What are Biosimilar Medicines and how Can they be Used to Treat People with Cancer?

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Plain Language Review: What are Biosimilar Medicines and how Can they be Used to Treat People with Cancer?

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date